fibroadipose

(redirected from fibrofatty)
Also found in: Dictionary.

fibroadipose

 [fi″bro-ad´ĭ-pōs]
both fibrous and fatty.

fi·bro·ad·i·pose

(fī'brō-ad'i-pōs),
Relating to or containing both fibrous and fatty structures.
Synonym(s): fibrofatty

fi·bro·ad·i·pose

(fī'brō-ad'i-pōs)
Relating to or containing both fibrous and fatty structures.
References in periodicals archive ?
On MRI, FAVA demonstrates high signal intensity due to the fibrofatty components on T1- and T2-weighted images.
Caption: Figure 3a--Macroscopic examination of right ventricular cavity, which was dilated and showing signs of transmural fibrofatty infiltration.
Fibrolipomatous hamartomas or neural fibrolipomas are benign fibrofatty tumors that arise from the epineurium, making these tumors difficult to resect (2).
Noninvasive approaches including computed tomography (CT) and magnetic resonance imaging enable observation of fibrofatty infiltration of the myocardium in healthy subjects and in conditions of cardiomyoptahy, states after myocardial infarction, arrhythmogenic right ventricular dysplasia, and others (5,14-17).
Chen et al., "Prolactin mediates effects of chronic psychological stress on induction of fibrofatty cells in the heart," American Journal of Translational Research, vol.
The histopathology result showed necrotic acutely inflamed fibrofatty tissue (Figure 2).
(d) Plexiform neurofibroma residing within the fibrofatty tissue adjacent to the gallbladder.
Atherosclerosis is popularly defined as an artery wall thickening triggered by accumulation of foam cells and proliferation of intimal smooth muscle cell, which results in a fibrofatty plaque.
AS is a specific form of arteriosclerosis in which an artery wall thickens as a result of invasion and accumulation of white blood cells (foam cells) and proliferation of intimal-smooth-muscle cell creating an atheromatous (fibrofatty) plaque.
As a result, his penile arteries were atherosclerosed (artery wall thickened as a result of invasion and accumulation of white blood cells and proliferation of intimal-smooth-muscle cell creating an fibrofatty plaque) preventing engorgement.
As breast development continues the fibrofatty and glandular tissues increase.
This sub-study included 331 patients enrolled in the GLAGOV trial and explored whether Repatha produced changes in individual plaque components (dense calcium, fibrous, fibrofatty, necrotic core) compared to placebo using virtual histology.